These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

313 related items for PubMed ID: 34666651

  • 1. [Burden of Pneumococcal Meningitis and Bacteremia, Serotype Distribution and Antibiotic Resistance in Healthy Children After Conjugated Pneumococcal Vaccine Implementation: Single Center Experience].
    Özdemir H, Ekin Dağ N, Çakmak Taşkın E, Konca HK, Arga G, Nar Ötgün S, Güriz H, Elhan A, Çiftçi E, İnce E.
    Mikrobiyol Bul; 2021 Oct; 55(4):492-506. PubMed ID: 34666651
    [Abstract] [Full Text] [Related]

  • 2. Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from Kuwait.
    Mokaddas E, Albert MJ.
    Vaccine; 2012 Dec 31; 30 Suppl 6():G37-40. PubMed ID: 23228356
    [Abstract] [Full Text] [Related]

  • 3. Antibiotic resistance and serotype distribution of invasive pneumococcal diseases before and after introduction of pneumococcal conjugate vaccine in the Kingdom of Saudi Arabia (KSA).
    Shibl AM, Memish ZA, Al-Kattan KM.
    Vaccine; 2012 Dec 31; 30 Suppl 6():G32-6. PubMed ID: 23228355
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The effects of pneumococcal conjugate vaccine (PCV7 and PCV13) on Turkish children with invasive pneumococcal disease: a single center experience.
    Özdemir H, Yıldız C, Nar Ötgün S, Erkol H, Karbuz A, Aldemir Kocabaş B, Tural Kara T, Gözalan A, Durmaz R, Çiftçi E, Aysev D, İnce E.
    Arch Argent Pediatr; 2017 Aug 01; 115(4):316-322. PubMed ID: 28737858
    [Abstract] [Full Text] [Related]

  • 6. Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway.
    Steens A, Bergsaker MA, Aaberge IS, Rønning K, Vestrheim DF.
    Vaccine; 2013 Dec 16; 31(52):6232-8. PubMed ID: 24176490
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The Effect of 13-Valent Pneumococcal Conjugate Vaccine on the Serotype Distribution and Antibiotic Resistance Profiles in Children With Invasive Pneumococcal Disease.
    Gaviria-Agudelo CL, Jordan-Villegas A, Garcia C, McCracken GH.
    J Pediatric Infect Dis Soc; 2017 Sep 01; 6(3):253-259. PubMed ID: 26907814
    [Abstract] [Full Text] [Related]

  • 10. The impact of a pneumococcal conjugate vaccination program on the nasopharyngeal carriage, serotype distribution and antimicrobial resistance of Streptococcus pneumoniae among healthy children in Turkey.
    Soysal A, Karabağ-Yılmaz E, Kepenekli E, Karaaslan A, Cagan E, Atıcı S, Atınkanat-Gelmez G, Boran P, Merdan S, Hasdemir U, Söyletir G, Bakır M.
    Vaccine; 2016 Jul 19; 34(33):3894-900. PubMed ID: 27269059
    [Abstract] [Full Text] [Related]

  • 11. Impact of pneumococcal conjugate vaccine (PCV7 and PCV13) on pneumococcal invasive diseases in Italian children and insight into evolution of pneumococcal population structure.
    Camilli R, D'Ambrosio F, Del Grosso M, Pimentel de Araujo F, Caporali MG, Del Manso M, Gherardi G, D'Ancona F, Pantosti A, Pneumococcal Surveillance Group.
    Vaccine; 2017 Aug 16; 35(35 Pt B):4587-4593. PubMed ID: 28716556
    [Abstract] [Full Text] [Related]

  • 12. Nasopharyngeal carriage of Streptococcus pneumoniae in healthy Turkish children after the addition of PCV7 to the national vaccine schedule.
    Ozdemir H, Ciftçi E, Durmaz R, Güriz H, Aysev AD, Karbuz A, Gökdemir R, Acar B, Nar Ötgün S, Ertek M, Köse SK, Ince E.
    Eur J Pediatr; 2014 Mar 16; 173(3):313-20. PubMed ID: 24046219
    [Abstract] [Full Text] [Related]

  • 13. Pediatric invasive pneumococcal disease caused by vaccine serotypes following the introduction of conjugate vaccination in Denmark.
    Harboe ZB, Valentiner-Branth P, Ingels H, Rasmussen JN, Andersen PH, Bjerre CC, Goldblatt D, Ashton L, Haston M, Konradsen HB, Lambertsen L, Danish Pneumococcal Surveillance Collaborating Group.
    PLoS One; 2013 Mar 16; 8(1):e51460. PubMed ID: 23365635
    [Abstract] [Full Text] [Related]

  • 14. Emerging Streptococcus pneumoniae Strains Colonizing the Nasopharynx in Children After 13-valent Pneumococcal Conjugate Vaccination in Comparison to the 7-valent Era, 2006-2015.
    Kaur R, Casey JR, Pichichero ME.
    Pediatr Infect Dis J; 2016 Aug 16; 35(8):901-6. PubMed ID: 27420806
    [Abstract] [Full Text] [Related]

  • 15. Expansion of serotype coverage in the universal pediatric vaccination calendar: short-term effects on age- and serotype-dependent incidence of invasive pneumococcal clinical presentations in Madrid, Spain.
    Picazo J, Ruiz-Contreras J, Casado-Flores J, Negreira S, García-de-Miguel MJ, Hernández-Sampelayo T, Otheo E, Méndez C, HERACLES Study Group.
    Clin Vaccine Immunol; 2013 Oct 16; 20(10):1524-30. PubMed ID: 23925887
    [Abstract] [Full Text] [Related]

  • 16. Comparative incidence dynamics and serotypes of meningitis, bacteremic pneumonia and other-IPD in young children in the PCV era: Insights from Israeli surveillance studies.
    Ben-Shimol S, Givon-Lavi N, Grisaru-Soen G, Megged O, Greenberg D, Dagan R, Israel Bacteremia and Meningitis Active Surveillance Group.
    Vaccine; 2018 Aug 28; 36(36):5477-5484. PubMed ID: 28579230
    [Abstract] [Full Text] [Related]

  • 17. Early trends for invasive pneumococcal infections in children after the introduction of the 13-valent pneumococcal conjugate vaccine.
    Kaplan SL, Barson WJ, Lin PL, Romero JR, Bradley JS, Tan TQ, Hoffman JA, Givner LB, Mason EO.
    Pediatr Infect Dis J; 2013 Mar 28; 32(3):203-7. PubMed ID: 23558320
    [Abstract] [Full Text] [Related]

  • 18. Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Nuorti JP, Whitney CG, Centers for Disease Control and Prevention (CDC).
    MMWR Recomm Rep; 2010 Dec 10; 59(RR-11):1-18. PubMed ID: 21150868
    [Abstract] [Full Text] [Related]

  • 19. Prevention of Antibiotic-Nonsusceptible Invasive Pneumococcal Disease With the 13-Valent Pneumococcal Conjugate Vaccine.
    Tomczyk S, Lynfield R, Schaffner W, Reingold A, Miller L, Petit S, Holtzman C, Zansky SM, Thomas A, Baumbach J, Harrison LH, Farley MM, Beall B, McGee L, Gierke R, Pondo T, Kim L.
    Clin Infect Dis; 2016 May 01; 62(9):1119-25. PubMed ID: 26908787
    [Abstract] [Full Text] [Related]

  • 20. Effects of PCV7 and PCV13 on invasive pneumococcal disease and carriage in Stockholm, Sweden.
    Galanis I, Lindstrand A, Darenberg J, Browall S, Nannapaneni P, Sjöström K, Morfeldt E, Naucler P, Blennow M, Örtqvist Å, Henriques-Normark B.
    Eur Respir J; 2016 Apr 01; 47(4):1208-18. PubMed ID: 26797033
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.